Heart Defect, Congenital

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Xeltis
XeltisNetherlands - Eindhoven
1 program
Xeltis Bioabsorbable Pulmonary Valved ConduitN/A1 trial
Active Trials
NCT03022708Active Not RecruitingEst. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
XeltisXeltis Bioabsorbable Pulmonary Valved Conduit

Clinical Trials (1)

NCT03022708XeltisXeltis Bioabsorbable Pulmonary Valved Conduit

Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study

Start: May 2017Est. completion: Dec 2026
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space